These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28392848)

  • 1. The synthetic biology puzzle: a qualitative study on public reflections towards a governance framework.
    Starkbaum J; Braun M; Dabrock P
    Syst Synth Biol; 2015 Dec; 9(4):147-157. PubMed ID: 28392848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safe and Sound? Scientists' Understandings of Public Engagement in Emerging Biotechnologies.
    Braun M; Starkbaum J; Dabrock P
    PLoS One; 2015; 10(12):e0145033. PubMed ID: 26660160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Let's (not) talk about synthetic biology: Framing an emerging technology in public and stakeholder dialogues.
    Bauer A; Bogner A
    Public Underst Sci; 2020 Jul; 29(5):492-507. PubMed ID: 32122265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A priority paper for the societal and ethical aspects of synthetic biology.
    Schmidt M; Ganguli-Mitra A; Torgersen H; Kelle A; Deplazes A; Biller-Andorno N
    Syst Synth Biol; 2009 Dec; 3(1-4):3-7. PubMed ID: 19816794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of problem setting and framing in citizen discussions on synthetic biology.
    Betten AW; Broerse JEW; Kupper F
    Public Underst Sci; 2018 Apr; 27(3):294-309. PubMed ID: 28597721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-creating a patient and public involvement and engagement 'how to' guide for researchers.
    Kaisler RE; Missbach B
    Res Involv Engagem; 2020; 6():32. PubMed ID: 32566249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic biology: mapping the scientific landscape.
    Oldham P; Hall S; Burton G
    PLoS One; 2012; 7(4):e34368. PubMed ID: 22539946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Decision Phases Framework for Public Engagement: Engaging Stakeholders about Gene Editing in the Wild.
    Barnhill-Dilling SK; Kokotovich A; Delborne JA
    Hastings Cent Rep; 2021 Nov; 51 Suppl 2():S48-S61. PubMed ID: 34905240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring Political Views on Synthetic Biology in the Netherlands.
    Rerimassie V
    Nanoethics; 2016; 10(3):289-308. PubMed ID: 28042348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A conceptual framework for understanding the perspectives on the causes of the science-practice gap in ecology and conservation.
    Bertuol-Garcia D; Morsello C; N El-Hani C; Pardini R
    Biol Rev Camb Philos Soc; 2018 May; 93(2):1032-1055. PubMed ID: 29160024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Tunisian experience of participatory health governance: the Societal Dialogue for Health (a qualitative study).
    Ben Mesmia H; Rajan D; Bouhafa Chtioui R; Koch K; Jaouadi I; Aboutaleb H; De Courcelles S; Atmani L; Pujos B; Mtiraoui A
    Health Res Policy Syst; 2023 Aug; 21(1):84. PubMed ID: 37641114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety risks and ethical governance of biomedical applications of synthetic biology.
    Ou Y; Guo S
    Front Bioeng Biotechnol; 2023; 11():1292029. PubMed ID: 37941726
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative, collaborative, and integrative risk governance for emerging technologies.
    Linkov I; Trump BD; Anklam E; Berube D; Boisseasu P; Cummings C; Ferson S; Florin MV; Goldstein B; Hristozov D; Jensen KA; Katalagarianakis G; Kuzma J; Lambert JH; Malloy T; Malsch I; Marcomini A; Merad M; Palma-Oliveira J; Perkins E; Renn O; Seager T; Stone V; Vallero D; Vermeire T
    Environ Syst Decis; 2018 May; 38(2):170-176. PubMed ID: 37829286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Science to the rescue or contingent progress? Comparing 10 years of public, expert and policy discourses on new and emerging science and technology in the United Kingdom.
    Smallman M
    Public Underst Sci; 2018 Aug; 27(6):655-673. PubMed ID: 28490253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Private and public values of innovation: A patent analysis of synthetic biology.
    Ribeiro B; Shapira P
    Res Policy; 2020 Feb; 49(1):103875. PubMed ID: 32015589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic biology regulation and governance: Lessons from TAPIC for the United States, European Union, and Singapore.
    Trump BD
    Health Policy; 2017 Nov; 121(11):1139-1146. PubMed ID: 28807332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "That was not the discussion we wanted to have": Engagement of civil society organizations with synthetic biology.
    Fuchs D; Bauer A; Bogner A
    Public Underst Sci; 2023 Aug; 32(6):676-690. PubMed ID: 37092655
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.